Back
Catalyst Pharmaceuticals Stock Price Chart
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
42
CPRX
Catalyst Pharmaceuticals
Last Price:
21.34
Seasonality Move:
-9.09%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.04 | Buy |
| 20-day SMA: | 20.13 | Buy |
| 50-day SMA: | 18.62 | Buy |
| 200-day SMA: | 16.12 | Buy |
| 8-day EMA: | 20.19 | Buy |
| 20-day EMA: | 19.88 | Buy |
| 50-day EMA: | 18.82 | Buy |
| 200-day EMA: | 16.5 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.43 | Buy |
| Relative Strength Index (14 RSI): | 62.11 | Buy |
| Chaikin Money Flow: | -81182 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.68 - 20.5) | Buy |
| Bollinger Bands (100): | (15.2 - 19.06) | Buy |
Catalyst Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 20.43 while CPRX 8-day simple moving average is 20.04, which is a Buy signal.
- The stock price of CPRX is 20.43 while Catalyst Pharmaceuticals 20-day SMA is 20.13, which makes it a Buy.
- Catalyst Pharmaceuticals 50-day simple moving average is 18.62 while CPRX share price is 20.43, making it a Buy technically.
- CPRX stock price is 20.43 and Catalyst Pharmaceuticals 200-day simple moving average is 16.12, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Sell
42
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a Sell
The current Catalyst Pharmaceuticals [CPRX] share price is $20.43. The Score for CPRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.42B
Price in USD:
20.43
Share Volume:
648.55K
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
20.87
52-Week Low:
11.55
Sell
42
Catalyst Pharmaceuticals (CPRX)
is a Sell
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?
The Catalyst Pharmaceuticals stock price is 20.43 USD today. -
Will CPRX stock go up or go down?
Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Catalyst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 20.43 while CPRX 8-day exponential moving average is 20.19, which is a Buy signal.
- The stock price of CPRX is 20.43 while Catalyst Pharmaceuticals 20-day EMA is 19.88, which makes it a Buy.
- Catalyst Pharmaceuticals 50-day exponential moving average is 18.82 while CPRX share price is 20.43, making it a Buy technically.
- CPRX stock price is 20.43 and Catalyst Pharmaceuticals 200-day simple moving average is 16.50, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
- CPRX Moving Average Covergence Divergence (MACD) indicator is 0.43, suggesting Catalyst Pharmaceuticals is a Buy
- Catalyst Pharmaceuticals Relative Strength Index (RSI) is 62.11, which suggest Catalyst Pharmaceuticals is overbought
- The Bollinger Bands (25) for Catalyst Pharmaceuticals is (19.68 - 20.5), which suggest Catalyst Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Catalyst Pharmaceuticals is (15.2 - 19.06), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.